Transcranial Doppler, Hydroxyurea Use Low for Sickle Cell Anemia

THURSDAY, Sept. 22, 2022 -- For children with sickle cell anemia (SCA), transcranial Doppler (TCD) ultrasound screening and hydroxyurea therapy use remains low, according to research published in the Sept. 20 early-release issue of the U.S. Centers...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news